In 1998, researchers isolated powerful stem cells from human embryos, sparking immense excitement about their potential to revolutionize medicine. These cells, capable of transforming into any cell type, were hailed as the key to repairing damaged organs and tissues. Despite the initial fervor, over two decades later, no treatments based on these embryonic stem cells have reached the market. The promise of a medical revolution remains unfulfilled, with ongoing investigations into why this is the case and when we might see changes. Meanwhile, the tech world sees its own shifts, with Meta ending third-party fact-checking and Elon Musk’s Twitter undergoing significant policy changes, highlighting the volatile nature of social media governance.
Source: www.technologyreview.com
